NOVARTIS AG-REG (1NOVN.MI) Stock Income Statement
Europe - BIT:1NOVN - CH0012005267 - Common Stock
113 EUR
+13 (+13%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 54.84B | 51.72B | 46.66B | 43.38B | 43.97B | |||
| Minority Interest Expense | 16.00M | 2.00M | -4.00M | 0.00 | 3.00M | |||
| Cost Of Goods | 13.10B | 12.81B | 12.02B | 11.21B | 11.39B | |||
| Gross Profit | 41.74B | 38.91B | 34.64B | 32.16B | 32.58B | |||
| Operating Expenses | 23.40B | 22.59B | 22.00B | 21.96B | 21.62B | |||
| Research and Development | 9.68B | 9.30B | 8.60B | 9.38B | 8.15B | |||
| Selling, General, and Administrative Expenses | 13.13B | 12.56B | 12.49B | 12.19B | 12.76B | |||
| Operating Income | 18.35B | 16.32B | 12.64B | 10.21B | 10.96B | |||
| Interest Income/Expense | -1.07B | -633.00M | -497.00M | -777.00M | 14.68B | |||
| Other Income/Expense | 170.00M | -85.00M | -60.00M | -115.00M | -108.00M | |||
| Non Recurring Items | -1.84B | -1.96B | -2.96B | -2.14B | -1.01B | |||
| Income Before Taxes | 15.61B | 13.64B | 9.12B | 7.18B | 24.53B | |||
| Income Tax | 1.97B | 1.70B | 551.00M | 1.13B | 1.63B | |||
| Net Income | 13.65B | 11.94B | 14.85B | 6.96B | 24.02B | |||
| EBITDA | 24.35B | 20.92B | 20.92B | 17.39B | 17.08B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 6.85 | 5.87 | 7.09 | 3.16 | 10.62 | |||
| Non GAAP EPS | 8.74 | 7.81 | 6.90 | 6.12 | 6.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 76.12% | 75.22% | 74.24% | 74.15% | 74.10% | |||
| Profit Margin | 24.90% | 23.09% | 31.83% | 16.03% | 54.63% | |||
| Operating Profit Margin | 33.45% | 31.55% | 27.09% | 23.53% | 24.93% | |||
All data in USD